abstract |
The disclosure relates to Ebola virus ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines. The vaccines include one or more RNA polynucleotides having an open reading frame encoding Ebola virus. Methods for preparing and using such vaccines are also described. |